<DOC>
	<DOCNO>NCT00689858</DOCNO>
	<brief_summary>TO assess PK/PD effect co-administerd Cilostazol Ginkgo biloba placebo , Phase I study healthy Volunteers design</brief_summary>
	<brief_title>Study Assess Effect Pharmacokinetics/Pharmacodynamics ( PK/PD ) Interaction After co-Administration Cilostazol With Ginkgo Biloba Placebo</brief_title>
	<detailed_description />
	<mesh_term>Cilostazol</mesh_term>
	<criteria>healthy male adult volunteer 19 45 year age within 15 % ideal body weight broca 's formula . subject n't congenital chronic disease symptoms sign diseases physical examination . ] subject abnornal lab . ( In particular , AST ALT &gt; 1.25 time upper limit / Total bilirubin &gt; 1.5 time upper limit/170,000 &lt; Platelet &lt; 360,000 / PT aPTT BT &gt; &gt; upper limit subject receive metabolic enzyme induce inhibit drug like barbiturate drink excess alcohol within 1 month prior study .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>